Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.

Int J Nanomedicine · 2006 · PMC2676642 · PMID 17722274

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The effect of peginterferon-alpha 2b on HIV RNA was comparable with that of peginterferon-alpha 2a; however, the higher efficacy of peginterferon-alpha as compared with standard interferons also caused a more pronounced increase in HIV RNA, although the differences did not reach statistical significance ( Carrat et al 2004 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.